Practice Areas

Follow us

Sanjeev Saraswat

Sanjeev Saraswat

Senior Of Counsel

education: B.Sc. (Hons) Maths, Delhi University, LL.B. Delhi University Admitted to the Bar in 1992

Admitted to the Bar in 1992. He brings with him significant experience in commercial and corporate litigation and regularly represents clients before various Courts and Tribunals. His niche area of practice includes settlement of disputes through arbitration and conciliation. Over the years, he has successfully assisted various clients in arbitration proceedings in India and other jurisdictions as well. He regularly advices clients on issues pertaining to real estate, venture capital and banking laws. He is an astute professional who brings in a “solution approach” to any dispute and specializes in strategizing the matter and achieving effective and time bound results.

He has extensive experience in handling commercial, corporate and commercial litigation, including prosecution related to economic offences, winding-up matters, matters under Negotiable Instruments Act, Sick Industrial Companies Act, Insolvency and Bankruptcy Code and appears before various courts and tribunals, including the Hon’ble Delhi High Court, Debt Recovery Tribunal (previously also before the BIFR and AAIFR). He has acquired niche knowledge in handling commercial arbitrations in India and overseas and also provides strategic guidance in handling disputes, statutory claims. He Regularly advises clients on diverse issues / claims arising under various indirect Tax Legislations.

Philosophy

He is an astute professional who brings in a “solution approach” to any dispute and specializes in strategizing the matter and achieving effective and time bound results

Asia Law Offices advised a major transnational strategic collaboration between its client, UAE-Based Pharmax Pharmaceuticals, and Swiss pharma major Acino Pharmaceuticals.

ALO represented Pharmax in the structuring and closure of entire transaction documents of the significant collaboration.

The collaboration framework extends to licensing, manufacturing, and supply of Acino formulations within the gastroenterology and the cardiovascular space throughout the Middle East and Africa.